Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

0.8800
-0.0100-1.12%
Volume:4K
Turnover:3.88K
Market Cap:40.91M
PE:-1.36
High:0.9312
Open:0.9049
Low:0.8611
Close:0.8900
52wk High:2.57
52wk Low:0.6300
Shares:46.49M
Float Shares:25.94M
Volume Ratio:0.36
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6464
EPS(LYR):-0.7584
ROE:-202.81%
ROA:-85.85%
PB:1.30
PE(LYR):-1.16

Loading ...

InspireMD director Paul Stuka acquires 20,000 common shares valued at $17,500

Reuters
·
May 30

InspireMD chair Paul Stuka to retire, won’t seek board reelection in 2027

Reuters
·
May 23

Top InspireMD Executive Makes Notable Move With Latest Stock Sale

TIPRANKS
·
May 22

InspireMD director Paul Stuka buys USD 17,325 common shares

Reuters
·
May 16

Top Executive Makes Bold Move With Fresh InspireMD Stock Purchase

TIPRANKS
·
May 14

InspireMD CEO Marvin Slosman acquires 21,000 shares valued at $25,200

Reuters
·
May 14

InspireMD director Paul Stuka buys common shares worth $87,125.56

Reuters
·
May 13

InspireMD Balances Fast Growth With U.S. Setback

TIPRANKS
·
May 11

Insiders Make Bold Moves as InspireMD Directors Load Up on Shares

TIPRANKS
·
May 09

InspireMD director Scott R. Ward acquires common shares worth $102,125

Reuters
·
May 09

InspireMD director Paul Stuka acquires 7,895 shares worth $9,053.79

Reuters
·
May 09

InspireMD director Gary S. Roubin acquires $106,200 in common shares

Reuters
·
May 09

InspireMD Q1 FY26 net loss widens 22.6% to $13.69 million; revenue more than doubles to $3.4 million

Reuters
·
May 07

InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference

GlobeNewswire
·
May 07

InspireMD Price Target Cut to $3.00/Share From $4.00 by Piper Sandler

Dow Jones
·
May 06

InspireMD Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

InspireMD Q1 revenue jumps 122%, beats estimates on product demand

Reuters
·
May 05

InspireMD Q1 FY26 net loss narrows to $13.7 million; revenue more than doubles to $3.4 million

Reuters
·
May 05

InspireMD Q1 EPS $(0.16) Beats $(0.19) Estimate, Sales $3.398M Beat $2.698M Estimate

Benzinga Earnings
·
May 05

InspireMD Inc - on Track for FDA Approval of Cguard Prime 80 Cm for Tcar in H2 2026

THOMSON REUTERS
·
May 05